3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Conditions
Arthritis, Rheumatoid
6
Spondylitis, Ankylosing
2
Psoriasis
2
Crohn Disease
2
Colitis, Ulcerative
2
Uveal Melanoma
1
Plaque Psoriasis
1
Melanoma
1
Hidradenitis Suppurativa
1
Healthy Adult Male
1
Healthy
1
Acne Vulgaris
1
Abscess
1
Interventions
Injections, Intradermal
1
Gels
1
Cyproterone Acetate
1
Adalimumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
INDUSTRY
×
Acne Vulgaris
×
Adalimumab
×
Clear all
NCT01635764
2018-01-24
PIONEER (OLE)
AbbVie
Phase 3
Completed
508 enrolled
9 charts